Newsroom

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Erasca, Inc. (NASDAQ: ERAS) between January 14, 2025 and April 26, 2026, inclusive (the “Class Period”). Erasca develops oncology therapies. For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegations: Rosen Law Firm is Investigating the Allegations that Erasca, Inc. (NASDAQ: ERAS) Misled...

GENÈVE--(BUSINESS WIRE)--Le Wyss Center for Bio and Neuroengineering à Genève a le plaisir d'annoncer la nomination de la Dre Tracy Laabs au poste de directrice, à compter du 1er 2026. Dre Laabs succède au Prof. Dr Erwin Böttinger, qui laisse derrière lui une organisation fondamentalement transformée : qui ne se contente plus de poursuivre une science révolutionnaire, mais la transforme systématiquement en entreprises qui atteignent les patients. Depuis qu’il a rejoint le Wyss Center en tant qu...

GENÈVE--(BUSINESS WIRE)--Het Wyss Center for Bio and Neuroengineering in Genève is verheugd de benoeming van dr. Tracy Laabs tot directeur aan te kondigen, met ingang van 1 juli 2026. Dr. Laabs volgt prof. dr. Erwin Böttinger op, die een fundamenteel getransformeerde organisatie achterlaat: een organisatie die niet langer alleen baanbrekend wetenschappelijk onderzoek nastreeft, maar dit systematisch omzet in projecten die patiënten ten goede komen. Sinds zijn aantreden als directeur van het Wys...

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired ADMA Biologics, Inc. (“ADMA” or the “Company”) (NASDAQ:ADMA) securities during the period of August 9, 2024 through March 25, 2026, inclusive (“the Class Period”).If you suffered a loss on your ADMA investments, you have until August 10, 2026 to request lead plaintiff appointment. Courts do not consider lead plaintiff applications submitted after...

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP is investigating potential claims against Kemper Corporation (“Kemper” or the “Company”) (NYSE:KMPR). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.[LEARN MORE ABOUT THE INVESTIGATION]What Happened?On May 6, 2026, Kemper stated that “[t]he increase in minimum liability limits effective January 1, 2025, ha...

BOLOGNE, Italie--(BUSINESS WIRE)--Le Centre italien de recherche sur le calcul haute performance, le big data et l'informatique quantique (ICSC) a inauguré aujourd'hui l'ordinateur quantique IQM Radiance 54 au sein de CINECA, l'un des principaux centres européens de supercalcul. Cette mise en service permet l'utilisation d'applications avancées dans les domaines de l'optimisation, de la simulation et de l'apprentissage automatique. IQM a précédemment annoncé son regroupement d'entreprises en co...

GENF--(BUSINESS WIRE)--Das Wyss Center for Bio and Neuroengineering in Genf gibt die Ernennung von Dr. Tracy Laabs zum Direktor mit Wirkung 1. Juli 2026 bekannt. Dr. Laabs tritt die Nachfolge von Prof. Dr. Erwin Böttinger an, der eine grundlegend umgestaltete Organisation hinterlässt: eine Organisation, die nicht mehr nur bahnbrechende wissenschaftliche Erkenntnisse anstrebt, sondern diese systematisch in Projekte umsetzt, die den Patienten zugutekommen. Seit seiner Ernennung zum Direktor des W...

GINEBRA--(BUSINESS WIRE)--El Wyss Center for Bio and Neuroengineering de Ginebra tiene el placer de anunciar el nombramiento de la Dra. Tracy Laabs como directora, con efecto a partir del 1 de julio de 2026. La Dra. Laabs sucede al Prof. Dr. Erwin Böttinger, quien deja tras de sí una organización que ha experimentado una transformación radical: una organización que ya no se limita a dedicarse a la investigación científica de vanguardia, sino que la convierte sistemáticamente en iniciativas que...

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until August 10, 2026 to file lead plaintiff applications in a securities class action lawsuit against Zillow Group, Inc. (NasdaqGS: ZG, Z) (“Zillow” or the “Company”), if they purchased or otherwise acquired Zillow Class A or Class C common stock between February 11, 2025 and May 7, 2026,...

GINEVRA--(BUSINESS WIRE)--Il Wyss Center for Bio and Neuroengineering di Ginevra è lieto di annunciare la nomina della dott.ssa Tracy Laabs in qualità di direttrice, a partire dal 1º luglio 2026. La dott.ssa Laabs prenderà il posto del prof. dott. Erwin Böttinger, che lascia un'organizzazione trasformata dalle basi, che non si limita più a perseguire scoperte scientifiche rivoluzionarie, ma le trasforma sistematicamente in iniziative che arrivano ai pazienti. Da quando è arrivato al Wyss Center...